Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Daijyo Inaguma"'
Autor:
Jin Iwasaki, Midori Hasegawa, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Daijyo Inaguma, Yukio Yuzawa
Publikováno v:
Fujita Medical Journal, Vol 3, Iss 4, Pp 97-100 (2017)
Background: Cell-free and concentrated ascites reinfusion therapy (CART) was approved by the National Insurance Scheme in 1981 in Japan and has since been used as a treatment modality for refractory ascites. Two filtration methods may be used for CAR
Externí odkaz:
https://doaj.org/article/9b267f326237451392aab89d4b285066
Autor:
Kazuo Takahashi, Haruna Arai, Hiroki Hayashi, Midori Hasegawa, Daijyo Inaguma, Soshiro Ogata, Shigehisa Koide, Yukio Yuzawa, Kenichi Uto, Jun Saegusa
Publikováno v:
Medicine
Rationale: Immunoglobulin G4 related disease (IgG4-RD) rarely coexists with other autoimmune diseases, though we had a patient whose primary clinical problem was shifted from IgG4-RD to systemic lupus erythematosus (SLE) after gastrectomy. The presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fc8d6dc91fb19a179847fa5c898f2a
https://pubmed.ncbi.nlm.nih.gov/30572454
https://pubmed.ncbi.nlm.nih.gov/30572454
Autor:
Keiji Horike, Yasuhiro Otsuka, Norihiko Goto, Asami Takeda, Yoshihiko Watarai, Daijyo Inaguma, Kunio Morozumi
Publikováno v:
Nephrology. 19:45-48
IgA nephropathy (IgAN) is recurrent after transplantation; however, its time of recurrence is unpredictable. To date, factors influencing IgAN recurrence have not been elucidated. We present a case of a 23-year-old man with end-stage renal disease (E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e22bb20e53a2ff5d7d81a30f4c3ce821
https://doi.org/10.1111/nep.12252
https://doi.org/10.1111/nep.12252
Autor:
Kensuke Joh, Norihiko Goto, Michael J. Mihatsch, Asami Takeda, Keiji Horike, Yasuhiro Otsuka, Kunio Morozumi, Yoshihiko Watarai, Daijyo Inaguma, Kazuharu Uchida
Publikováno v:
Clinical Transplantation. 26:58-63
Fibronectin glomerulopathy (FNG) is a rare, autosomal dominant renal disease with massive mesangial, and subendothelial fibronectin deposits. It presents proteinuria, often in the nephrotic range in the third to fourth decade, and slow progression to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ec21e2be507c813893999001e720b6
https://doi.org/10.1111/j.1399-0012.2012.01644.x
https://doi.org/10.1111/j.1399-0012.2012.01644.x
Autor:
Kazuharu Uchida, Taisei Suzuki, Minako Murata, Yoshiaki Ogiyama, Takehiko Kawaguchi, Keiji Horike, Norihiko Goto, Yasuhiro Otsuka, Asami Takeda, Yukako Yamauchi, Daijyo Inaguma, Yoshihiko Watarai, Yutaka Yamaguchi, Kunio Morozumi
Publikováno v:
Clinical Transplantation. 25:23-27
Calcineurin inhibitors (CNI) have been commonly used as pivotal immunosuppressive agents to renal transplant recipients and have contributed significantly to improving short-term allograft survival. However, long-term administration of CNI may cause
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7ec8345ea0502f339b355f124344010
https://doi.org/10.1111/j.1399-0012.2011.01474.x
https://doi.org/10.1111/j.1399-0012.2011.01474.x
Autor:
Daijyo Inaguma, Kazutaka Kukita, Kazumichi Ohta, Syuichi Tsutsui, Satoshi Kurihara, Morimasa Kuwahara, Noritaka Onoda, Yoshiki Nishizawa, Hideki Tahara, Yoshinari Tsuruta, Yoshihiro Tominaga, Susumu Matsuoka, Motoko Tanaka
Publikováno v:
Therapeutic Apheresis and Dialysis. 10:198-204
We evaluated the relationship between the volume of parathyroid glands estimated by ultrasonography (US) and response of 22-oxa calcitriol (Maxacalcitol, OCT) in patients with secondary hyperparathyroidism (2HPT) to evaluate whether the volume can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3885bd6eafd466181248d195c7c07aa0
https://doi.org/10.1111/j.1744-9987.2006.00364.x
https://doi.org/10.1111/j.1744-9987.2006.00364.x
Autor:
Yasuhiro, Otsuka, Asami, Takeda, Keiji, Horike, Daijyo, Inaguma, Norihiko, Goto, Yoshihiko, Watarai, Kunio, Morozumi
Publikováno v:
Nephrology (Carlton, Vic.). 19
IgA nephropathy (IgAN) is recurrent after transplantation; however, its time of recurrence is unpredictable. To date, factors influencing IgAN recurrence have not been elucidated. We present a case of a 23-year-old man with end-stage renal disease (E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07358eb2500fe76633002868b564cabc
https://pubmed.ncbi.nlm.nih.gov/24842823
https://pubmed.ncbi.nlm.nih.gov/24842823
Autor:
Kazuharu Uchida, Yoshihiko Watarai, Daijyo Inaguma, Kunio Morozumi, Asami Takeda, Keiji Horike, Yasuhiro Otsuka, Norihiko Goto
Publikováno v:
Clinical transplantation. 26
A 53-yr-old woman with end-stage renal disease was admitted for renal transplantation (RTX). About a decade ago, she had presented with urinary abnormalities. Monoclonal IgA lambda was detected. Renal biopsy showed nodular glomerulosclerosis, and an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ba29d2fbc5895fcc4184aa4bd9a64d
https://pubmed.ncbi.nlm.nih.gov/22747479
https://pubmed.ncbi.nlm.nih.gov/22747479
Autor:
Keiji, Horike, Asami, Takeda, Yutaka, Yamaguchi, Yoshiaki, Ogiyama, Yukako, Yamauchi, Minako, Murata, Takehiko, Kawaguchi, Taisei, Suzuki, Yasuhiro, Otsuka, Daijyo, Inaguma, Norihiko, Goto, Yoshihiko, Watarai, Kazuharu, Uchida, Kunio, Morozumi
Publikováno v:
Clinical transplantation. 25
Calcineurin inhibitors (CNI) have been commonly used as pivotal immunosuppressive agents to renal transplant recipients and have contributed significantly to improving short-term allograft survival. However, long-term administration of CNI may cause
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a9210e0e9954fdf0a7867392a2f6132
https://pubmed.ncbi.nlm.nih.gov/21623910
https://pubmed.ncbi.nlm.nih.gov/21623910
Autor:
Jun-ichi Kawada, Hiroshi Kimura, Izumi Hirose, Daijyo Inaguma, Kimiyasu Shiraki, Kenzo Ono, Satoko Shimada, Hideaki Ymamaguchi
Publikováno v:
European Journal of Pediatrics. 165:280-281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911f092e3b61e86e94808304c4cf65fe
https://doi.org/10.1007/s00431-005-0066-z
https://doi.org/10.1007/s00431-005-0066-z